Interleukin-4 as an emerging therapeutic target for IgG4-related disease | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Correspondence

Interleukin-4 as an emerging therapeutic target for IgG4-related disease

Free

Online download statistics by month:

Online download statistics by month: January 2020 to April 2022

	Abstract	Full	Pdf
Jan 2020	358	349	125
Feb 2020	332	328	52
Mar 2020	116	115	22
Apr 2020	55	52	38
May 2020	44	40	15
Jun 2020	43	41	11
Jul 2020	44	43	15
Aug 2020	40	37	8
Sep 2020	37	31	10
Oct 2020	31	30	8
Nov 2020	20	16	8
Dec 2020	21	20	12
Jan 2021	25	24	14
Feb 2021	35	32	14
Mar 2021	27	26	3
Apr 2021	9	9	5
May 2021	51	50	8
Jun 2021	18	15	4
Jul 2021	35	33	17
Aug 2021	25	25	18
Sep 2021	18	17	7
Oct 2021	23	21	22
Nov 2021	43	40	10
Dec 2021	86	84	6
Jan 2022	400	402	38
Feb 2022	149	148	36
Mar 2022	44	43	10
Apr 2022	71	71	15
Total	2200	2142	551